{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:27:31Z","timestamp":1782563251861,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00216-013-7154-0","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T05:08:09Z","timestamp":1373260089000},"page":"7367-7375","source":"Crossref","is-referenced-by-count":38,"title":["A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study"],"prefix":"10.1007","volume":"405","author":[{"given":"Paul L. A. M.","family":"Corstjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herma H.","family":"Fidder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karien C.","family":"Wiesmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia J.","family":"de Dood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Rispens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan","family":"Wolbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Hommes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Tanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"7154_CR1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajg.2011.73","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P (2011) Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106:644\u2013659","journal-title":"Am J Gastroenterol"},{"key":"7154_CR2","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/ard.2010.146852","volume":"70","author":"DE Furst","year":"2010","unstructured":"Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F et al (2010) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010. Ann Rheum Dis 70:i2\u2013i36","journal-title":"Ann Rheum Dis"},{"key":"7154_CR3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","volume":"30","author":"DM Knight","year":"1992","unstructured":"Knight DM, Trinh H, Le J, Siegel S, Shealy D, Mcdonough M, Scallon B, Moore MA, Vilcek J, Daddona P, Ghrayeb J (1992) Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443\u20131453","journal-title":"Mol Immunol"},{"key":"7154_CR4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","volume":"348","author":"F Baert","year":"2003","unstructured":"Baert F, Noman M, Vermeire S, Van AG, D\u2019 HG, Carbonez A, Rutgeerts P (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 348:601\u2013608","journal-title":"N Engl J Med"},{"key":"7154_CR5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cgh.2006.06.025","volume":"4","author":"EA Maser","year":"2006","unstructured":"Maser EA, Villela R, Silverberg MS, Greenberg GR (2006) Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol 4:1248\u20131254","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7154_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/gast.2003.50145","volume":"124","author":"RJ Farrell","year":"2003","unstructured":"Farrell RJ, Alsahli M, Jeen YT, Falchuk KR, Peppercorn MA, Michetti P (2003) Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology 124:917\u2013924","journal-title":"Gastroenterology"},{"key":"7154_CR7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ibd.20177","volume":"13","author":"M Regueiro","year":"2007","unstructured":"Regueiro M, Siemanowski B, Kip KE, Plevy S (2007) Infliximab dose intensification in Crohn's disease. Inflamm Bowel Dis 13:1093\u20131099","journal-title":"Inflamm Bowel Dis"},{"key":"7154_CR8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1542-3565(04)00238-1","volume":"2","author":"SB Hanauer","year":"2004","unstructured":"Hanauer SB, Wagner CL, Bala M, Mayer L, Travers S, Diamond RH, Olson A, Bao W, Rutgeerst P (2004) Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol 2:542\u2013553","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7154_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/gut.2009.201533","volume":"60","author":"S Ben-Horin","year":"2011","unstructured":"Ben-Horin S, Yavzori M, Katz L, Kopylov U, Picard O, Fudim E, Coscas D, Bar-Meir S, Goldstein I, Chowers Y (2011) The immunogenic part of infliximab is the F(ab\u2019)2, but measuring antibodies to the intact infliximab molecule is more clinically useful. Gut 60:41\u201348","journal-title":"Gut"},{"key":"7154_CR10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","volume":"56","author":"S Vermeire","year":"2007","unstructured":"Vermeire S, Noman M, Van AG, Baert F, D\u2019Haens G, Rutgeerts P (2007) Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut 56:1226\u20131231","journal-title":"Gut"},{"key":"7154_CR11","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1572-0241.2007.01638.x","volume":"103","author":"MA Ainsworth","year":"2008","unstructured":"Ainsworth MA, Bendtzen K, Brynskov J (2008) Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. Am J Gastroenterol 103:944\u2013948","journal-title":"Am J Gastroenterol"},{"key":"7154_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2009.183095","volume":"59","author":"CH Seow","year":"2010","unstructured":"Seow CH, Newman A, Irwin SP, Steinhart AH, Silverberg MS, Greenberg GR (2010) Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut 59:49\u201354","journal-title":"Gut"},{"key":"7154_CR13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/ard.2008.092833","volume":"68","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, Svenson M, Eijsbouts AM, van den Hoogen FH, Enevold C, Van Riel PL, Bendtzen K (2009) Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis 68:1739\u20131745","journal-title":"Ann Rheum Dis"},{"key":"7154_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ajg.2011.103","volume":"106","author":"H Yanai","year":"2011","unstructured":"Yanai H, Hanauer SB (2011) Assessing response and loss of response to biological therapies in IBD. Am J Gastroenterol 106:685\u2013698","journal-title":"Am J Gastroenterol"},{"key":"7154_CR15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2010.9","volume":"105","author":"W Afif","year":"2010","unstructured":"Afif W, Loftus EV Jr, Faubion WA, Kane SV, Bruining DH, Hanson KA, Sandborn WJ (2010) Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol 105:1133\u20131139","journal-title":"Am J Gastroenterol"},{"key":"7154_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14712598.2012.644271","volume":"12","author":"P Miheller","year":"2012","unstructured":"Miheller P, Kiss LS, Lorinczy K, Lakatos PL (2012) Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use? Expert Opin Biol Ther 12:179\u2013192","journal-title":"Expert Opin Biol Ther"},{"key":"7154_CR17","first-page":"62","volume":"152","author":"PLAM Corstjens","year":"2005","unstructured":"Corstjens PLAM, Li S, Zuiderwijk M, Kardos K, Abrams WR, Niedbala RS, Tanke HJ (2005) Infrared up-converting phophors for bioassays. IEE Proc Nanobiotechnol 152:62\u201372","journal-title":"IEE Proc Nanobiotechnol"},{"key":"7154_CR18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.clinbiochem.2011.06.983","volume":"44","author":"PLAM Corstjens","year":"2011","unstructured":"Corstjens PLAM, de Dood CJ, van der Ploeg-van Schip, Wiesmeijer KC, Riuttamaki T, van Meijgaarden KE, Spencer JS, Tanke HJ, Ottenhoff THM, Geluk A (2011) Lateral flow assay for simultaneous detection of cellular- and humoral immune responses. Clin Biochem 44:1241\u20131246","journal-title":"Clin Biochem"},{"key":"7154_CR19","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/clinchem\/47.10.1885","volume":"47","author":"P Corstjens","year":"2001","unstructured":"Corstjens P, Zuiderwijk M, Brink A, Li S, Feindt H, Neidbala RS, Tanke H (2001) Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin Chem 47:1885\u20131893","journal-title":"Clin Chem"},{"key":"7154_CR20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinbiochem.2007.12.015","volume":"41","author":"PL Corstjens","year":"2008","unstructured":"Corstjens PL, Zuiderwijk M, Tanke HJ, van der Ploeg-van Schip JJ, Ottenhoff TH, Geluk A (2008) A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells. Clin Biochem 41:440\u2013444","journal-title":"Clin Biochem"},{"key":"7154_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/abio.2001.5105","volume":"293","author":"RS Niedbala","year":"2001","unstructured":"Niedbala RS, Feindt H, Kardos K, Vail T, Burton J, Bielska B et al (2001) Detection of analytes by immunoassay using up-converting phosphor technology. Anal Biochem 293:22\u201330","journal-title":"Anal Biochem"},{"key":"7154_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1196\/annals.1384.021","volume":"1098","author":"VK Mokkapati","year":"2007","unstructured":"Mokkapati VK, Sam NR, Kardos K, Perez RJ, Guo M, Tanke HJ, Corstjens PL (2007) Evaluation of UPlink-RSV: prototype rapid antigen test for detection of respiratory syncytial virus infection. Ann N Y Acad Sci 1098:476\u2013485","journal-title":"Ann N Y Acad Sci"},{"key":"7154_CR23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.2004.030452","volume":"64","author":"GJ Wolbink","year":"2005","unstructured":"Wolbink GJ, Voskuyl AE, Lems WF, de Groot E, Nurmohamed MT, Tak PP, Dijkmans BAC, Aarden L (2005) Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64:704\u2013707","journal-title":"Ann Rheum Dis"},{"key":"7154_CR24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jim.2011.09.011","volume":"375","author":"T Rispens","year":"2012","unstructured":"Rispens T, de Vrieze H, de Groot E, Wouters D, Stapel S, Wolbink GJ, Aarden LA (2012) Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testing. J Immunol Methods 375:93\u201399","journal-title":"J Immunol Methods"},{"key":"7154_CR25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1196\/annals.1384.016","volume":"1098","author":"PLAM Corstjens","year":"2007","unstructured":"Corstjens PLAM, Chen ZY, Zuiderwijk M, Bau HH, Abrams WR, Malamud D, Niedbala RS, Tanke HJ (2007) Rapid assay format for multiplex detection of humoral immune responses to infectious disease pathogens (HIV, HCV, and TB). Ann N Y Acad Sci 1098:437\u2013445","journal-title":"Ann N Y Acad Sci"},{"key":"7154_CR26","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sanborn WJ (2007) Inflammatory bowel disease: clinical aspects and established an evolving therapies. Lancet 369:1641\u20131657","journal-title":"Lancet"},{"key":"7154_CR27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/00365521.2010.536254","volume":"46","author":"C Steenholdt","year":"2011","unstructured":"Steenholdt C, Bendtzen K, Brynskov J, Thomsen OO, Ainsworth MA (2011) Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease. Scand J Gastroenterol 46:310\u2013318","journal-title":"Scand J Gastroenterol"},{"key":"7154_CR28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/00365520802699278","volume":"44","author":"K Bendtzen","year":"2009","unstructured":"Bendtzen K, Ainsworth M, Steenholdt C, Thomsen OO, Brynskov J (2009) Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies. Scand J Gastroenterol 44:774\u2013781","journal-title":"Scand J Gastroenterol"},{"key":"7154_CR29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cgh.2012.10.020","volume":"11","author":"S Ben-Horin","year":"2013","unstructured":"Ben-Horin S, Waterman M, Kopylov U, Yavzori M, Picard O, Fudim E, Awadi H, Weiss B, Chowers Y (2013) Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11:444\u2013447","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7154_CR30","author":"ME Valk van der","year":"2012","unstructured":"van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH et al (2012) Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: results from the COIN study. Gut. doi: 10.1136\/gutjnl-2012-303376","journal-title":"Gut"},{"key":"7154_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/BOR.0b013e328329ed8b","volume":"21","author":"GJ Wolbink","year":"2009","unstructured":"Wolbink GJ, Aarden LA, Dijkmans BA (2009) Dealing with immunogenicity of biologicals: assessment and clinical relevance. Curr Opin Rheumatol 21:211\u2013215","journal-title":"Curr Opin Rheumatol"},{"key":"7154_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.diagmicrobio.2010.10.011","volume":"69","author":"KC Iregbu","year":"2011","unstructured":"Iregbu KC, Esfandiari J, Nnorom J, Sonibare SA, Uwaezuoke SN, Eze SO, Abdullahi N, Lawal AO, Durogbola BS (2011) Dual path platform HIV 1\/2 assay: evaluation of a novel rapid test using oral fluids for HIV screening at the National Hospital in Abuja, Nigeria. Diagn Microbiol Infect Dis 69:405\u2013409","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7154_CR33","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1039\/b913960e","volume":"9","author":"DM Bruls","year":"2009","unstructured":"Bruls DM, Evers TH, Kahlman JA, van Lankvelt PJ, Ovsyanko M, Pelssers EG (2009) Rapid integrated biosensor for multiplexed immunoassays based on actuated magnetic nanoparticles. Lab Chip 9:3504\u20133510","journal-title":"Lab Chip"},{"key":"7154_CR34","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ibd.20976","volume":"15","author":"S Marel van der","year":"2009","unstructured":"van der Marel S, Duijvestein M, Hardwick JC, van den Brink GR, Veenendaal R, Hommes DW, Fidder HH (2009) Quality of web-based information on inflammatory bowel diseases. Inflamm Bowel Dis 15:1891\u20131896","journal-title":"Inflamm Bowel Dis"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-013-7154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-013-7154-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-013-7154-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:12:50Z","timestamp":1596067970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-013-7154-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["7154"],"URL":"https:\/\/doi.org\/10.1007\/s00216-013-7154-0","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}